NeuralStem Inc. ALS Investigator Presents Long-Term Follow Up Phase I Data

One patient showed functional improvement from pre-treatment baseline, which is maintained to present day. The other two patients are maintaining the same level of functionality as they had at the baseline for over three years since the stem cell treatment.

http://ift.tt/1uy2GlX